Ashes of 166 people lost after blunder by firm offering 'funerals in space'
The ashes of more than 150 people have been lost - and are unlikely to be recovered - after a company which promises " funerals in space" suffered a catastrophic glitch.
The Nyx Mission Possible had seen a module containing the urns orbit the planet twice in late June. It was supposed to return the objects to Earth and the bereaved families but communication with the capsule was lost during re-entry, and it crashed into the Pacific Ocean.
In addition to the 166 human remains, the module also carried plant material and cannabis seeds. The cargo was part of an experiment on the effects of microgravity on the cultivation of the plant, with a focus on future missions to Mars. The mission was carried out by TEC for the American company Celestis, which offers memorial flights to space.
Celestis has now conceded "it will not be possible to recover or return the flight capsules" and TEC has apologised to customers who had "entrusted [them] with their cargo".
Celestis' service sees families send ashes or DNA samples of people and pets for a posthumous tribute. After orbiting Earth, the capsule returns. A video of key moments from the mission is provided to commemorate "the day your loved one touched the sky," Celestis says.
The company, founded in 1994, has already sent the remains of people linked to the science fiction work Star Trek into space, including the series' creator, Gene Roddenberry.
But the blunder this week saw communications with the capsule lost at an altitude of 26 km (16 miles). An investigation is underway into the loss of contact, after which the device plunged into the Pacific Ocean.
In a statement posted on LinkedIn, TEC said: "From an orbital altitude of 550 km (340 miles), the capsule successfully re-entered in a controlled manner, with communication re-established after maximum warm-up. However, communications were lost at an altitude of 26 km, shortly before the phase preceding parachute deployment." In a previous statement, TEC apologised "to all our customers who entrusted us with their cargo."
Charles Chafer, CEO of Celestis, which hired TEC, said this was the first mission in which capsules would return to Earth. He said: "As a result of this unexpected event, we believe it will not be possible to recover or return the flight capsules. We share the families' disappointment and offer our sincerest gratitude for their trust.
"We hope families will find some comfort in knowing their loved ones were part of a historic journey. Launched into space, orbiting the Earth, and now resting in the vastness of the Pacific, akin to a traditional and honorable scattering at sea."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mirror
a day ago
- Daily Mirror
Coldplay kiss cam joke branded 'tone deaf' as Stroke Association issues apology
American tech company, Astronomer, made headlines worldwide after former executive Andy Byron was caught canoodling his colleague, Kristin Cabot, at a Coldplay concert in Boston The Stroke Association has apologised for making an 'offensive joke' following the Coldplay kiss cam scandal. American tech company, Astronomer, made headlines worldwide on the weekend after former executive Andy Byron was caught canoodling his colleague, Kristin Cabot, at the British band's gig in Boston. Andy, who is married to someone else - as is Kristin - has now resigned from his role. However, the memes and jokes, poking fun at the scandal are still all over the internet. Getting in on the action, the Stroke Association made its own joke when the clip went viral, sharing a snap of the canoodling colleagues with the caption: "Us: 'Nothing destroys live and families quicker than a stroke.' *Viva La Vida plays softly in the distance*. *Coldplay has entered the chat.*" READ MORE: Coldplay kiss cam scandal: CEO's wife 'hiding' at $2.4m mansion 100 miles from marital home Responding to the post on Threads, many were appalled, with Sector Communications Consultant Tom Fishenden telling the Civil Society: 'I wouldn't be surprised if this one post has turned off some donors from the organisation." However, the Stroke Association has now deleted the post and apologised for its "huge lapse in judgement". Taking to LinkedIn, Juliet Bouverie, Chief Executive of the Stroke Association said: "On Friday we shared a post on Threads that used a viral moment to highlight the devastating impact of stroke. Whilst typically we would try to raise awareness of stroke in a way that aligns with the style and tone of the relevant social platform, capitalising on someone else's misfortune, in a way which also caused offence amongst some stroke survivors, was ill-informed and a huge lapse in judgment, for which we are extremely sorry." Conceding that the post was "short-sighted", Bouverie continued: "This isn't how we usually speak about stroke — a condition that changes lives in an instant and leaves a deep impact on survivors, families and carers. The post was shortsighted and undermined the severity of the condition which we deeply regret. "We're also sorry for how we initially responded to criticism. It didn't show the empathy or thoughtfulness that our community rightly deserves from us and that we pride ourselves on. We removed the post from Threads and are taking action to guarantee this can never happen again." Following the furore, which is now global news, cheating multi-millioanire Byron 's wife is reportedly hiding out at the family's $2.4million Maine mansion while holding crisis talks over the future of their marriage. Megan Byron, 50, is said to be laying low at their luxury property in Kennebunk, 106 miles away from their $1.4million marital home in Northborough, Massachusetts after her husband was caught looking cosy with his colleague. Byron and the company's HR boss Cabot were caught "all over each other" at the British band's gig before their secret was revealed to the world. The former CEO was captured with his arms wrapped around Ms Cabot as they snuggled up before Coldplay frontman Chris Martin accidentally exposed their extra-marital romance. The clip has now racked up millions of views online, but fresh footage has allegedly shown the pair snogging before their public outing. As the scandal continues to rumble on, with Mr Byron resigning from his position at Astronomer, his wife is thought to be surrounded by loved ones in the wake of her husband's misdemeanour.
Scottish Sun
2 days ago
- Scottish Sun
Two NHS drugs slows and could REVERSE devastating Alzheimer's, ‘exciting' study finds
Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) TWO NHS drugs could be combined to treat, and even reverse, the most common form of dementia, scientists claim. A pair of cancer drugs have been identified as a powerful duo that may tackle Alzheimer's disease, after scientists sifted through 1,300 approved medicines. Sign up for Scottish Sun newsletter Sign up 1 Alzheimer's was reversed in mice Credit: Alamy The American team used cutting-edge computer tools to match the gene changes seen in Alzheimer's patients with medicines that reverse those effects. They found that two cancer drugs, both already available on the NHS, reduced brain degeneration in mice with the disease, and even brought back their memory. The study, from the University of California, San Francisco (UCSF), first looked at how Alzheimer's alters the activity of individual brain cells. They then searched for existing drugs that trigger the opposite changes, with the aim of rewiring damaged neurons and brain cells called glia. And when they tested the top two candidates, letrozole and irinotecan, in lab mice, the results were impressive. One theory of how Alzheimer's comes about is that sticky proteins - like amyloid-beta - start clumping together in the brain years before symptoms appear. These toxic clumps block communication between brain cells and trigger inflammation, eventually causing the cells to die. Some scientists believe this buildup is the root cause of Alzheimer's, so clearing it could stop the disease in its tracks. When combined, the cancer drugs not only halted brain cell damage but also undid toxic clumps of proteins, restored memory and reversed the disease's genetic footprint. Prof Marina Sirota, senior author, said: 'We're excited that our computational approach led us to a potential combination therapy for Alzheimer's based on existing FDA-approved medications.' Common painkiller used for back pain ups risk of dementia by 29%, scientists warn She added: 'Alzheimer's disease comes with complex changes to the brain, which has made it tough to study and treat — but our tools opened up the possibility of tackling that complexity directly.' The scientists then trawled through the anonymised medical records of 1.4million over-65s and found those already taking the cancer drugs were less likely to develop Alzheimer's. Dr Yaqiao Li, the study's lead author, said: 'Thanks to all these existing data sources, we went from 1,300 drugs, to 86, to 10, to just five. 'In particular, the rich data collected by all the UC health centres pointed us straight to the most promising drugs. It's kind of like a mock clinical trial.' Letrozole is typically used to treat breast cancer, while irinotecan is prescribed for colon and lung cancer. Both are already used in the UK. 'So exciting' Prof Yadong Huang, co-senior author, said: 'Alzheimer's is likely the result of numerous alterations in many genes and proteins that, together, disrupt brain health. 'This makes it very challenging for drug development - which traditionally produces one drug for a single gene or protein that drives disease.' He added: 'It's so exciting to see the validation of the computational data in a widely used Alzheimer's mouse model.' The breakthrough, published in the journal Cell, could fast-track trials in humans. Prof Sirota said: 'If completely independent data sources, such as single-cell expression data and clinical records, guide us to the same pathways and the same drugs and then resolve Alzheimer's in a genetic model then maybe we're onto something.' She added: 'We're hopeful this can be swiftly translated into a real solution for millions of patients with Alzheimer's.' Alzheimer's causes a relentless decline in cognition, learning, and memory. But decades of research have only produced two FDA-approved drugs, neither of which can meaningfully slow the decline. In the UK, no disease-modifying drugs are currently approved or available. Instead, the UK relies on symptom-managing drugs, such as Donepezil and Rivastigmine.
Metro
3 days ago
- Metro
Legendary sci-fi film dubbed 'one of the best ever made' streaming for free
An iconic 80s horror film lauded as 'terrifying' and 'remarkable' is streaming now for free on ITVX. Released in 1982, The Thing quickly garnered a cult following after its home video release and has since become one of the most influential sci-fi films of all time. It is based on the 1938 novella Who Goes There? by John W. Campbell Jr., and followed the 1951 film adaptation The Thing From Another World. The Thing tells the story of a group of American researchers in Antarctica who come across an extraterrestrial life form that can infiltrate the bodies of other living organisms and imitate them to go undetected. Starring Kurt Russell, Keith David, A. Wilford Brimley, and many more, it was met with mixed reception at the time of its release, being praised for its special effects but criticised for the gory body horror at the same time. It failed to make an impact at the box office but became a sleeper hit when it was released on home video and shown on television, since being reappraised as 'one of the best science fiction films ever made.' The Thing was followed by a novelisation in the same year, comic book sequels, board games, video games, and a 2011 prequel film of the same name. It holds an 82% rating on Rotten Tomatoes, with the critics' consensus reading: 'Grimmer and more terrifying than the 1950s take, John Carpenter's The Thing is a tense sci-fi thriller rife with compelling tension and some remarkable make-up effects.' In their review, The Times wrote: 'The solemnity of the frozen wastes contrasts brilliantly with the sweaty paranoia of the men, who are unsure which of their colleagues is next going to erupt with hidden jaws and shooting tendrils.' Empire said: 'The Thing is a peerless masterpiece of relentless suspense, retina-wrecking visual excess and outright, nihilistic terror.' praised: 'Every October, I revisit John Carpenter's 'The Thing' to celebrate the month of Halloween, and every year I arrive at the same conclusion: it's one of the most effective horror films ever made.' Meanwhile, Loud and Clear reviews added: 'In my eyes, The Thing is as perfect as a movie can get: it knows exactly what it wants to be and what it's trying to do, and succeeds on every level I can conceive.' Many hailed director John Carpenter, with Radio Times saying he 'stresses the slimy ET at the expense of characterisation, mood and practically everything else, yet it's precisely this one grisly facet that makes it such compelling science fiction.' Speaking to The Guardian, the horror icon behind titles such as Halloween and Escape From New York opened up about why he thinks The Thing has stood the test of time as well as addressing why he chose to leave one huge unanswered question right at the end. 'Audiences didn't like the ending. They wanted to know who the Thing was – which was left up in the air. They hated that but I don't care, that's the way I wanted to end it,' he began. More Trending 'The film was about the end of the world. Its bleakness was the reason it wasn't a success at the time, but I think also why it has endured. In fact the film was an enormous failure. 'I got fired because of it and was out of work for a while, but slowly its reputation changed. Not everybody's convinced, though. There are still plenty of people who think it's a piece of trash.' The Thing is streaming now on ITVX . Got a story? If you've got a celebrity story, video or pictures get in touch with the entertainment team by emailing us celebtips@ calling 020 3615 2145 or by visiting our Submit Stuff page – we'd love to hear from you. MORE: Acclaimed thriller hailed as a 'masterpiece' now available to stream MORE: 'A shark ate my arm and leg – I wouldn't change a thing' MORE: 'Worst film ever' ripped apart by critics in one-star reviews
